Cellular immunophenotypes in human embryonic, fetal and adult heart

Romanian Journal of Morphology and Embryology

Volumn 53, Issue 2, 2012, Pages 299-311

  Grigore, Alina ^a   Arsene, D ^a   Filipoiu, Fl ^b   Cionca, Florina ^a   Enache, Simona ^a   Ceausu M ^b   Comǎnescu, Maria ^a,b   Stǎniceanu, Florica ^b   Ardeleanu, Carmen ^a,b  

^a VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Cardiac development; Heart; Immunohistochemistry; Ischemic disease

Indexed keywords

EID: 84865006195     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Liao R, Pfister O, Jain M, Mouquet F, Global atlas on cardiovascular disease prevention and control, Cardiovascular disease, World Health Organization: http://www.who.int/cardiovascular_diseases/en/, 2011.
2. Liao R, Pfister O, Jain M, Mouquet F, The bone marrow-cardiac axis of myocardial regeneration, Prog Cardiovasc Dis, 2007, 50(1):18-30.
3. Souders CA, Bowers SL, Baudino TA, Cardiac fibroblasts: the renaissance cell, Circ Res, 2009, 105(12):1164-1176.
4. Tamiolakis D, Papadopoulos N, Sivridis E, Anastasiadis P, Karamanidis D, Romanidis C, Kotini A, Bounovas A, Simopoulos C, Expression of the intermediate filament vimentin and fibrillar proteins of the extracellular matrix related to embryonal heart development, Clin Exp Obstet Gynecol, 2001, 28(3):193-195.
5. Goldsmith EC, Hoffman A, Morales MO, Potts JD, Price RL, McFadden A, Rice M, Borg TK, Organization of fibroblasts in the heart, Dev Dyn, 2004, 230(4):787-794.
6. Ottaviano FG, Yee KO, Communication signals between cardiac fibroblasts and cardiac myocytes, J Cardiovasc Pharmacol, 2011, 57(5):513-521.
7. Noseda M, Schneider MD, Fibroblasts inform the heart: control of cardiomyocyte cycling and size by age-dependent paracrine signals, Dev Cell, 2009, 16(2):161-162.
8. Kakkar R, Lee RT, Intramyocardial fibroblast-myocyte communication, Circ Res, 2010, 106(1):45-57.
9. Camelliti P, Borg TK, Kohl P, Structural and functional characterisation of cardiac fibroblasts, Cardiovasc Res, 2005, 65(1):40-51.
10. Porter KE, Turner NA, Cardiac fibroblasts: at the heart of myocardial remodeling, Pharmacol Ther, 2009, 123(2):255-278.
11. Zhang Y, Kanter EM, Yamada KA, Remodeling of cardiac fibroblasts following myocardial infarction results in increased gap junction intercellular communication, Cardiovasc Pathol, 2010, 19(6):e233-e240.
12. Baudino TA, Carver W, Giles W, Borg TK, Cardiac fibroblast: friend or foe? Am J Physiol Heart Circ Physiol, 2006, 291(3):H1015-1026.
13. Morley ME, Riches K, Peers C, Porter KE, Hypoxic inhibition of human cardiac fibroblast invasion and MMP-2 activation may impair adaptive myocardial remodelling, Biochem Soc Trans, 2007, 35(Pt 5):905-907.
14. Piera-Velasquez S, Li Z, Jimenez SA, Role of endothelialmesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders, Am J Pathol, 2011, 179(3):1074-1080.
15. Schneider M, Andersen DC, Silahtaroglu A, Lyngbæk S, Kauppinen S, Hansen JL, Sheikh SP, Cell-specific detection of microRNA expression during cardiomyogenesis by combined in situ hybridization and immunohistochemistry, J Mol Histol, 2011, 42(4):289-299.
16. Chen D, Assad-Kottner C, Orrego C, Torre-Amione G, Cytokines and acute heart failure, Crit Care Med, 2008, 36(1 Suppl):S9-S16.
17. Shiba Y, Hauch KD, Laflamme MA, Cardiac applications for human pluripotent stem cells, Curr Pharm Des, 2009, 15(24):2791-2806.
18. Person AD, Klewer SE, Runyan RB, Cell biology of cardiac cushion development, Int Rev Cytol, 2005, 243:287-335.
19. Harris IS, Black BL, Development of the endocardium, Pediatr Cardiol, 2010, 31(3):391-399.
20. Potta SP, Liang H, Winkler J, Doss MX, Chen S, Wagh V, Pfannkuche K, Hescheler J, Sachinidis A, Isolation and functional characterization of alpha-smooth muscle actin expressing cardiomyocytes from embryonic stem cells, Cell Physiol Biochem, 2010, 25(6):595-604.
21. Anderson RH, Ho SY, Becker AE, Anatomy of the human atrioventricular junctions revisited, Anat Rec, 2000, 260(1): 81-91.
22. Burstein B, Libby E, Calderone A, Nattel S, Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences, Circulation, 2008, 117(13):1630-1641.
23. Small EM, Thatcher JE, Sutherland LB, Kinoshita H, Gerard RD, Richardson JA, Dimaio JM, Sadek H, Kuwahara K, Olson EN, Myocardin-related transcription factor-a controls myofibroblast activation and fibrosis in response to myocardial infarction, Circ Res, 2010, 107(2): 294-304.
24. Lin YZ, Cai JM, Chen L, Yang ZP, Zhang JC, Wu W, Ke D, Xu CX, Relationship between atrial fibroblast proliferation/ fibrosis and atrial fibrillation in patients with rheumatic heart disease, Zhonghua Xin Xue Guan Bing Za Zhi, 2009, 37(9):813-817.
25. Naq AC, Krehel W, Cheng M, Distribution of vimentin and desmin filaments in embryonic cardiac muscle cells in culture, Cytobios, 1986, 45(182-183):195-209.
26. McLendon PM, Robbins J, Desmin-related cardiomyopathy: an unfolding story, Am J Physiol Heart Circ Physiol, 2011, 301(4):H1220-H1228.
27. Capetanaki Y, Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function, Trends Cardiovasc Med, 2002, 12(8):339-348.
28. Kim HD, Expression of intermediate filament desmin and vimentin in the human fetal heart, Anat Rec, 1996, 246(2): 271-278.
29. Yamamoto M, Abe S, Rodríguez-Vázquez JF, Fujimiya M, Murakami G, Ide Y, Immunohistochemical distribution of desmin in the human fetal heart, J Anat, 2011, 219(2):253-258.
30. Di Somma S, Di Benedetto MP, Salvatore G, Agozzino L, Ferranti F, Esposito S, La Dogana P, Scarano MI, Caputo G, Cotrufo M, Santo LD, de Divitiis O, Desmin-free cardiomyocytes and myocardial dysfunction in end stage heart failure, Eur J Heart Fail, 2004, 6(4):389-398.
31. Pawlak A, Gil RJ, Kasprzak J, Walczak E, Słysz A, Cardiomyocyte desmin abnormalities-an accurate predictor of long-term survival in patients with chronic heart failure, Kardiol Pol, 2009, 67(7):724-733.
32. Ouyang J, Guzman M, Desoto-Lapaix F, Pincus MR, Wieczorek R, Utility of desmin and a Masson's trichrome method to detect early acute myocardial infarction in autopsy tissues, Int J Clin Exp Pathol, 2009, 3(1):98-105.
33. Katsumoto T, Mitsushima A, Kurimura T, The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction, Biol Cell, 1990, 68(2):139-146.
34. Ryu K, Li L, Khrestian CM, Matsumoto N, Sahadevan J, Ruehr ML, Van Wagoner DR, Efimov IR, Waldo AL, Effects of sterile pericarditis on connexins 40 and 43 in the atria: correlation with abnormal conduction and atrial arrhythmias, Am J Physiol Heart Circ Physiol, 2007, 293(2):H1231-H1241.
35. Melchior-Becker A, Dai G, Ding Z, Schäfer L, Schrader J, Young MF, Fischer JW, Deficiency of biglycan causes cardiac fibroblasts to differentiate into a myofibroblast phenotype, J Biol Chem, 2011, 286(19):17365-17375.
36. Baruscotti M, Robinson RB, Electrophysiology and pacemaker function of the developing sinoatrial node, Am J Physiol Heart Circ Physiol, 2007, 295(5):H2613-H2623.
37. Mommersteeg MT, Hoogaars WM, Prall OW, de Gier-de Vries C, Wiese C, Clout DE, Papaioannou VE, Brown NA, Harvey RP, Moorman AF, Christoffels VM, Molecular pathway for the localized formation of the sinoatrial node, Circ Res, 2007, 100(3):354-362.
38. Waldo KL, Lo CW, Kirby ML, Connexin 43 expression reflects neural crest patterns during cardiovascular development, Dev Biol, 1999, 208(2):307-323.
39. Walker DL, Vacha SJ, Kirby ML, Lo CW, Connexin43 deficiency causes dysregulation of coronary vasculogenesis, Dev Biol, 2005, 284(2):479-498.
40. Yu ZB, Sheng JJ, Remodeling of cardiac gap junctions and arrhythmias, Sheng Li Xue Bao, 2011, 63(6):586-592.
41. Chen Z, Luo H, Zhuang M, Cai L, Su C, Lei Y, Zou J, Effects of ischemic preconditioning on ischemia/reperfusioninduced arrhythmias by upregulation of connexin 43 expression, J Cardiothorac Surg, 2011, 6:80.
42. Miura T, Milki T, Yano T, Role of gap junction in ischemic preconditioning in the heart, Am J Physiol Heart Circ Physiol, 2010, 298(4):H1115-H1125.
43. Vogel WF, Abdulhussein R, Ford CE, Sensing extracellular matrix: an update on discoidin domain receptor function, Cell Signal, 2006, 18(8):1108-1116.
44. Vogel W, Discoidin domain receptors: structural relations and functional implications, FASEB J, 1999, 13(Suppl):S77-S82.
45. Morales MO, Price RL, Goldsmith EC, Expression of Discoidin Domain Receptor 2 (DDR2) in the developing heart, Microsc Microanal, 2005, 11(3):260-267.
46. Abe S, Suzuki M, Cho KH, Murakami G, Cho BH, Ide Y, CD34-positive developing vessels and other structures in human fetuses: an immunohistochewmical study, Surg Radiol Anat, 2011, 33(10):919-927.
47. Yang J, Ii M, Kamei N, Alev C, Kwon SM, Kawamoto A, Akimaru H, Masuda H, Sawa Y, Asahara T, CD34+ cells represent highly functional endothelial progenitor cells in murine bone marrow, PloS One, 2011, 6(5):e20219.
48. Mackie AR, Losordo DW, CD34-positive stem cells in the treatment of heart and vascular disease in human beings, Tex Heart Inst J, 2011, 38(5):474-485.
49. Limana F, Zacheo A, Mocini D, Mangoni A, Borsellino G, Diamantini A, De Mori R, Battistini L, Vigna E, Santini M, Loiaconi V, Pompilio G, Germani A, Capogrossi MC, Identification of myocardial and vascular precursor cells in human and mouse epicardium, Circ Res, 2007, 101(12): 1255-1265.
50. Feng M, Xiang JZ, Ming ZY, Fu Q, Ma R, Zhang QF, Dun YY, Yang L, Liu H, Activation of epidermal growth factor receptor mediates reperfusion arrhythmias in anaesthetized rats, Cardiovasc Res, 2012, 93(1):60-68.
51. Williams-Pritchard G, Knight M, Hoe LS, Headrick JP, Peart JN, Essential role of EGFR in cardioprotection and signaling responses to A1 adenosine receptors and ischemic preconditioning, Am J Physiol Heart Circ Physiol, 2011, 300(6):H2161-H2168.
52. Gaur M, Ritner C, Sievers R, Pedersen A, Prasad M, Bernstein HS, Yeghiazarians Y, Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes, Cytotherapy, 2010, 12(6):807-817.
53. Ai W, Zhang Y, Tang QZ, Yan L, Bian ZY, Liu C, Huang H, Bai X, Yin L, Li H, Silibinin attenuates cardiac hypertrophy and fibrosis through blocking EGFR-dependent signaling, J Cell Biochem, 2010, 110(5):1111-1122.
54. Smith NJ, Chan HW, Qian H, Bourne AM, Hannan KM, Warner FJ, Ritchie RH, Pearson RB, Hannan RD, Thomas WG, Determination of the exact molecular requirements for type 1 angiotensin receptor epidermal growth factor receptor transactivation and cardiomyocyte hypertrophy, Hypertension, 2011, 57(5):973-980.
55. Tallini YN, Greene KS, Craven M, Spealman A, Breitbach M, Smith J, Fisher PJ, Steffey M, Hesse M, Doran RM, Woods A, Singh B, Yen A, Fleischmann BK, Kotlikoff MI, c-kit expression identifies cardiovascular precursors in the neonatal heart, Proc Natl Acad Sci U S A, 2009, 106(6):1808-1813.
56. Di Meglio F, Castaldo C, Nurzynska D, Romano V, Miraglia R, Bancone C, Langella G, Vosa C, Montagnani S, Epithelial-mesenchymal transition of epicardial mesothelium is a source of cardiac CD117-positive stem cells in adult human heart, J Mol Cell Cardiol, 2010, 49(5):719-727.
57. Zaruba MM, Soonpaa M, Reuter S, Field LJ, Cardiomyogenic potential of C-kit(+)-expressing cells derived from neonatal and adult mouse hearts, Circulation, 2010, 121(18): 1992-2000.
58. Sandstedt J, Jonsson M, Lindahl A, Jeppsson A, Asp J, C-kit+ CD45-cells found in the adult human heart represent a population of endothelial progenitor cells, Basic Res Cardiol, 2010, 105(4):545-556.
59. Goldsmith EC, Zhang X, Watson J, Hastings J, Potts JD, The collagen receptor DDR2 is expressed during early cardiac development, Anat Rec (Hoboken), 2010, 293(5): 762-769.